{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By REBECCA R. RUIZ and KATIE THOMAS", "person": [{"middlename": "R.", "firstname": "Rebecca", "lastname": "RUIZ", "rank": 1, "role": "reported", "organization": ""}, {"rank": 2, "role": "reported", "firstname": "Katie", "organization": "", "lastname": "THOMAS"}]}, "abstract": "Pharmaceutical company Cephalon will pay $1.2 billion to settle antitrust charges with Federal Trade Commission, largest settlement ever secured by FTC; company was charged with blocking generic competitors from entering market as patents expired on its lucrative sleep drug Provigil.", "type_of_material": "News", "word_count": "1048", "lead_paragraph": "The agency accused the company of illegally blocking generic competition to Provigil, a sleep-disorder drug.", "pub_date": "2015-05-29T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Teva Settles Cephalon Generics Case With F.T.C. for $1.2 Billion", "print_headline": "F.T.C. Settles Suit With Drug Maker "}, "snippet": "The agency accused the company of illegally blocking generic competition to Provigil, a sleep-disorder drug.", "multimedia": [{"height": 126, "url": "images/2015/05/29/business/29FTC/29FTC-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/05/29/business/29FTC/29FTC-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/05/29/business/29FTC/29FTC-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/05/29/business/29FTC/29FTC-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/05/29/business/29FTC/29FTC-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/05/29/business/29FTC/29FTC-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/05/29/business/teva-cephalon-provigil-ftc-settlement.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Cephalon Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Federal Trade Commission", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Antitrust Laws and Competition Issues", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "5", "is_major": "Y", "value": "Generic Brands and Products", "name": "subject"}], "blog": [], "_id": "5567169438f0d86f0b8505d7", "source": "The New York Times"}